Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
ESC Heart Fail. 2020 Oct;7(5):2175-2183. doi: 10.1002/ehf2.12838. Epub 2020 Jun 30.
Cardiovascular diseases constitute one of the main aetiologies of mortality among patients with cancer. Population ageing and cancer survival rate improvements have resulted in the coexistence of cardiovascular diseases and malignancies in an increasing number of patients. With the diversity in treatments and the introduction of new drug lines, multiple mechanisms of cardiovascular injury have been recognized in these patients. Cardio-oncology is an emerging entity introduced to provide a proper solution to the several challenges encountered in the management of patients with cancer and cardiac involvement. This review will assess the logical grounds for establishing a cardio-oncology unit, describe the main objectives and the detailed responsibilities in such systems, and outline the target population. Furthermore, the importance of research and appropriate data collection will be highlighted. Lastly, the special considerations and modifications required for setting up such centres in the developing countries are discussed.
心血管疾病是癌症患者死亡的主要病因之一。人口老龄化和癌症存活率的提高导致越来越多的患者同时患有心血管疾病和恶性肿瘤。随着治疗方法的多样化和新药物线的引入，这些患者的心血管损伤机制已得到广泛认识。肿瘤心脏病学是一种新兴的实体，旨在为癌症患者和心脏受累患者的管理中遇到的各种挑战提供适当的解决方案。本综述将评估建立肿瘤心脏病学单位的逻辑依据，描述此类系统的主要目标和详细职责，并概述目标人群。此外，还将强调研究和适当数据收集的重要性。最后，讨论了在发展中国家建立此类中心所需的特殊考虑和修改。
